# OnCo record jose-baselga (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jose-baselga/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jose-baselga" ;
  schema:name "José Baselga"@en ;
  schema:description "Spanish oncologist who helped develop trastuzumab, pertuzumab and everolimus for breast cancer, and was lead author of BOLERO-2, which established everolimus plus exemestane for hormone-receptor-positive disease."@en ;
  schema:url <https://onco.cc/people/jose-baselga/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Jos%C3%A9_Baselga> ;
  onco:tag "breast", "targeted-therapy", "trialist" ;
  schema:jobTitle "Medical oncologist and drug developer (1959–2021)" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:trials <https://onco.cc/trials/bolero-2/> .